Grey Market Premium · Jul 14 – Jul 16, 2025 · Issue Price ₹570
Last updated:
The Anthem Biosciences IPO GMP is ₹179.00, last updated on 21 Jul 2025, 12:00 AM IST, indicating 31.4% expected listing gain, or about ₹4,654 per lot of 26 shares.
The Anthem Biosciences IPO Grey Market Premium (GMP) is currently trading at ₹179.00 in the unofficial grey market. Based on this, the expected listing price is ₹749.00, implying a +31.4% gain over the issue price of ₹570. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Last recorded GMP of each day (IST), newest first. Est. listing = upper price band + GMP.
| Date | GMP (₹) | Change | Est. Listing | Profit / Lot | Subject-to | Trend |
|---|---|---|---|---|---|---|
| 21 Jul 2025 12:00 am | +₹179.00 (31.4%) | +₹2.00 | ₹749.00 | ₹4,654 | ₹3,500 | ▲ Up |
| 20 Jul 2025 12:00 am | +₹177.00 (31.1%) | +₹14.00 | ₹747.00 | ₹4,602 | ₹3,500 | ▲ Up |
| 19 Jul 2025 12:00 am | +₹163.00 (28.6%) | — | ₹733.00 | ₹4,238 | ₹3,200 | — |
Over the last 3 days with GMP data (19 Jul – 21 Jul 2025), the Anthem Biosciences IPO GMP moved from ₹163.00 to ₹179.00, a net change of +₹16.00 (+2.8% of the upper price band). It closed higher on 2, lower on 0 and unchanged on 0 of those days compared with the day before.
Plain calculations from our recorded entries. Rising = net change above +5% of the upper price band, falling = below −5%, stable = in between.
Grey market premium over time (₹)
3 entries recorded, newest first. Trend compares each entry with the one before it.
| # | Date / Time | GMP (₹) | Exp. Listing | Exp. Gain | Trend |
|---|---|---|---|---|---|
| 1 | Jul 21, 2025 12:00 am | +₹179.00 | ₹749.00 | +31.4% | ▲ Up |
| 2 | Jul 20, 2025 12:00 am | +₹177.00 | ₹747.00 | +31.1% | ▲ Up |
| 3 | Jul 19, 2025 12:00 am | +₹163.00 | ₹733.00 | +28.6% | — |
Want to understand how GMP works and how to estimate listing price? Read our guide on What is GMP in IPO.
The latest Anthem Biosciences IPO GMP is ₹179.00, recorded on 21 Jul 2025, 12:00 AM IST. At the ₹570 upper price band, this points to an estimated listing price of ₹749.00 (+31.4%).
Over the last 3 days with GMP data (19 Jul – 21 Jul 2025), the GMP moved from ₹163.00 to ₹179.00, a net change of +₹16.00 (+2.8% of the upper price band). That is a Stable trend by our definition: above +5% of the upper price band is rising, below −5% is falling, anything in between is stable.
The current GMP of ₹179.00 is +31.4% of the ₹570 upper price band (GMP ÷ upper price band × 100).
On 21 Jul 2025, the GMP closed at ₹179.00, up ₹2.00 from ₹177.00 on 20 Jul 2025.
The highest GMP we have recorded for Anthem Biosciences IPO is ₹179.00, on 21 Jul 2025, 12:00 AM IST.
Over the last 3 days with GMP data, the Anthem Biosciences IPO GMP ranged from ₹163.00 to ₹179.00.
At the current GMP of ₹179.00 and a lot size of 26 shares, the estimated profit is ₹4,654.00 per lot (GMP × lot size), before charges and taxes. It is indicative only.
Our team updates the Anthem Biosciences IPO GMP manually through the day while the IPO is active. We have recorded 3 entries since 19 Jul 2025; the latest was on 21 Jul 2025, 12:00 AM IST.
The subject-to rate is ₹3,500, which applies only if the application receives an allotment.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Anthem Biosciences IPO is expected to list on July 21, 2025 on NSE & BSE.
Not reliably. GMP shows what grey market participants were willing to pay at a point in time; the listing price is set by demand on the exchange on listing day and can differ widely from the last GMP.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.